Fraud Alert
Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails
and websites falsely offering employment opportunities in our name.
We never request payment from applicants. If you receive suspicious communications claiming
to represent our company, please contact us directly to verify authenticity.
Long-Term Study Offers Reassurance to Early Breast Cancer Survivors
The risk of developing a second primary cancer after being treated for early invasive breast cancer is only slightly higher than the general population, according to a new study.
Health News is provided as a service to Gateway Pharmacy site users by HealthDay. Gateway Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.